Maze Therapeutics, Inc.
MAZE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | $52 | -$100 | -$115 |
| Dep. & Amort. | $3 | $4 | $4 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $10 | $9 | $7 |
| Change in WC | -$2 | -$6 | -$3 |
| Other Non-Cash | $12 | $7 | $8 |
| Operating Cash Flow | $76 | -$87 | -$99 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$2 |
| Net Acquisitions | $0 | $0 | -$1 |
| Inv. Purchases | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$0 | -$3 |
| Financing Activities | – | – | – |
| Debt Repay. | $24 | $16 | $0 |
| Stock Issued | $68 | $0 | $2 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 |
| Financing Cash Flow | $93 | $16 | $2 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $168 | -$71 | -$101 |
| Supplemental Information | – | – | – |
| Beg. Cash | $30 | $101 | $202 |
| End Cash | $198 | $30 | $101 |
| Free Cash Flow | $75 | -$87 | -$101 |